Human papillomavirus in head and neck cancer

Cancers

Volumn 6, Issue 3, 2014, Pages 1705-1726

  Garbuglia, Anna Rosa ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Cancer; Human papillomavirus; Oral

Indexed keywords

BETAPAPILLOMAVIRUS; CANCER INCIDENCE; CORRELATION ANALYSIS; GAMMAPAPILLOMAVIRUS; GENOTYPE; GENOTYPING TECHNIQUE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 10; HUMAN PAPILLOMAVIRUS TYPE 2; HUMAN PAPILLOMAVIRUS TYPE 25; HUMAN PAPILLOMAVIRUS TYPE 28; HUMAN PAPILLOMAVIRUS TYPE 29; HUMAN PAPILLOMAVIRUS TYPE 3; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 43; HUMAN PAPILLOMAVIRUS TYPE 57; HUMAN PAPILLOMAVIRUS TYPE 78; HUMAN PAPILLOMAVIRUS TYPE 91; HUMAN PAPILLOMAVIRUS TYPE 94; MULTIPLEX CUTANEOUS PAPILLOMAVIRUS GENOTYPING ASSAY; MUPAPILLOMAVIRUS; NUPAPILLOMAVIRUS; OROPHARYNX CANCER; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; VIRUS DETECTION; WART VIRUS;

EID: 84936947714     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers6031705     Document Type: Review

References (81)

1. Chaturvedi, A.K.; Engels, E.A.; Pfeiffer, R.M.; Hernandez, B.Y.; Xiao, W.; Kim, E.; Jiang, B.; Goodman, M.T.; Sibug-Saber, M.; Cozen, W.; et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 2011, 29, 4294-4301.
2. Bravo, I.G.; de Sanjosé, S.; Gottschling, M. The clinical importance of understanding the evolution of papillomaviruses. Trends Microbiol. 2010, 18, 432-438.
3. Papillomavirus Episteme. Available online: http://pave.niaid.nih.gov/ (accessed on 15 March 2014).
4. Van Ranst, M.; Kaplan, J.B.; Burk, R.D. Phylogenetic classification of human papillomaviruses: Correlation with clinical manifestations. J. Gen. Virol. 1992, 73, 2653-2660.
5. Ghittoni, R.; Accardi, R.; Hasan, U.; Gheit, T.; Sylla, B.; Tommasino, M. The biological properties of E6 and E7 oncoproteins from human papillomaviruses. Virus Genes 2010, 40, 1-13.
6. Hubert, P.; Caberg, J.H.; Gilles, C.; Bousarghin, L.; Franzen-Detrooz, E.; Boniver, J.; Delvenne, P. E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol. 2005, 206, 346-355.
7. Ronco, L.V.; Karpova, A.Y.; Vidal, M.; Howley, P.M. Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev. 1998, 12, 2061-2072.
8. Park, J.S.; Kim, E.J.; Kwon, H.J.; Hwang, E.S.; Namkoong, S.E.; Um, S.J. Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein. Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis. J. Biol. Chem. 2000, 275, 6764-6769.
9. De Villiers, E.M.; Fauquet, C.; Broker, T.R.; Bernard, H.U.; zur Hausen, H. Classification of papillomaviruses. Virology 2004, 324, 17-27.
10. De Villiers, E.M. Cross-roads in the classification of papillomaviruses. Virology 2013, 445, 2-10.
11. Martin, E.; Dang, J.; Bzhalava, D.; Stern, J.; Edelstein, Z.R.; Koutsky, L.A.; Kiviat, N.B.; Feng, Q. Characterization of three novel human papillomavirus types isolated from oral rinse samples of healthy individuals. J. Clin. Virol. 2014, 59, 30-37.
12. Bernard, H.U.; Burk, R.D.; Chen, Z.; van Doorslaer, K.; zur Hausen, H.; de Villiers, E.M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401, 70-79.
13. Hsueh, P.R. Human papillomavirus, genital warts, and vaccines. J. Microbiol. Immunol. Infect. 2009, 42, 101-106.
14. Guan, P.; Howell-Jones, R.; Li, N.; Bruni, L.; de Sanjosé, S.; Franceschi, S.; Clifford, G.M. Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer. Int. J. Cancer 2012, 131, 2349-2359.
15. Li, N.; Franceschi, S.; Howell-Jones, R.; Snijders, P.J.; Clifford, G.M. Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication. Int. J. Cancer 2011, 128, 927-935.
16. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality, and Prevalence Worldwide in 2012. Available online: http://globocan.iarc.fr/ (accessed on 1 April 2014).
17. Danaei, G.; Vander Hoorn, S.; Lopez, A.D.; Murray, C.J.; Ezzati, M. Comparative Risk Assessment collaborating group (Cancers). Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet 2005, 366, 1784-1793.
18. Kim, H.J.; Fay, M.P.; Feuer, E.J.; Midthune, D.N. Permutation tests for joinpoint regression with applications to cancer rates. Stat. Med. 2000, 19, 335-351.
19. Franceschi, S.; Bidoli, E.; Herrero, R.; Muñoz, N. Comparison of cancers of the oral cavity and pharynx worldwide: Etiological clues. Oral. Oncol. 2000, 36, 106-115.
20. Smith, E.M.; Hoffman, H.T.; Summersgill, K.S.; Kirchner, H.L.; Turek, L.P.; Haugen, T.H. Human papillomavirus and risk of oral cancer. Laryngoscope 1998, 108, 1098-1103.
21. Schwartz, S.M.; Daling, J.R.; Doody, D.R.; Wipf, G.C.; Carter, J.J.; Madeleine, M.M.; Mao, E.J.; Fitzgibbons, E.D.; Huang, S.; Beckmann, A.M.; et al. Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J. Natl. Cancer Inst. 1998, 90, 1626-1636.
22. Gillison, M.L.; Koch, W.M.; Capone, R.B.; Spafford, M.; Westra, W.H.; Wu, L.; Zahurak, M.L.; Daniel, R.W.; Viglione, M.; Symer, D.E.; et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 2000, 92, 709-720.
23. Fouret, P.; Monceaux, G.; Temam, S.; Lacourreye, L.; St Guily, J.L. Human papillomavirus in head and neck squamous cell carcinomas in nonsmokers. Arch. Otolaryngol. Head Neck Surg. 1997, 123, 513-516.
24. Paz, I.B.; Cook, N.; Odom-Maryon, T.; Xie, Y.; Wilczynski, S.P. Human papillomavirus (HPV) in head and neck cancer. An association of HPV 16 with squamous cell carcinoma of Waldeyer's tonsillar ring. Cancer 1997, 79, 595-604.
25. Rabkin, C.S.; Biggar, R.J.; Melbye, M.; Curtis, R.E. Second primary cancers following anal and cervical carcinoma: Evidence of shared etiologic factors. Am. J. Epidemiol. 1992, 136, 54-58.
26. Kreimer, A.R.; Clifford, G.M.; Boyle, P.; Franceschi, S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: A systematic review. Cancer Epidemiol. Biomark. Prev. 2005, 14, 467-475.
27. Lace, M.J.; Anson, J.R.; Klussmann, J.P.; Wang, D.H.; Smith, E.M.; Haugen, T.H.; Turek, L.P. Human papillomavirus type 16 (HPV-16) genomes integrated in head and neck cancers and in HPV-16-immortalized human keratinocyte clones express chimeric virus-cell mRNAs similar to those found in cervical cancers. J. Virol. 2011, 85, 1645-1654.
28. Kreimer, A.R.; Clifford, G.M.; Snijders, P.J.; Castellsagué, X.; Meijer, C.J.; Pawlita, M.; Viscidi, R.; Herrero, R.; Franceschi, S.; International Agency for Research on Cancer (IARC) Multicenter Oral Cancer Study Group. HPV16 semiquantitative viral load and serologic biomarkers in oral and oropharyngeal squamous cell carcinomas. Int. J. Cancer 2005, 115, 329-332.
29. Braakhuis, B.J.; Snijders, P.J.; Keune, W.J.; Meijer, C.J.; Ruijter-Schippers, H.J.; Leemans, C.R.; Brakenhoff, R.H. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus. J. Natl. Cancer Inst. 2004, 96, 998-1006.
30. Näsman, A.; Attner, P.; Hammarstedt, L.; Du, J.; Eriksson, M.; Giraud, G.; Ahrlund-Richter, S.; Marklund, L.; Romanitan, M.; Lindquist, D.; et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of viral-induced carcinoma? Int. J. Cancer 2009, 125, 362-366.
31. Hong, A.M.; Grulich, A.E.; Jones, D.; Lee, C.S.; Garland, S.M.; Dobbins, T.A.; Clark, J.R.; Harnett, G.B.; Milross, C.G.; O'Brien, C.J.; et al. Squamous cell carcinoma of the oropharynx in Australian males induced by human papillomavirus vaccine targets. Vaccine 2010, 28, 3269-3272.
32. Hammarstedt, L.; Lindquist, D.; Dahlstrand, H.; Romanitan, M.; Dahlgren, L.O.; Joneberg, J.; Creson, N.; Lindholm, J.; Ye, W.; Dalianis, T.; et al. Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int. J. Cancer 2006, 119, 2620-2623.
33. Nagpal, J.K.; Patnaik, S.; Das, B.R. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int. J. Cancer 2002, 97, 649-653.
34. Gillison, M.L.; Alemany, L.; Snijders, P.J.; Chaturvedi, A.; Steinberg, B.M.; Schwartz, S.; Castellsagué, X. Human papillomavirus and diseases of the upper airway: Head and neck cancer and respiratory papillomatosis. Vaccine 2012, 30, F34-F54.
35. Kreimer, A.R.; Bhatia, R.K.; Messeguer, A.L.; González, P.; Herrero, R.; Giuliano, A.R. Oral human papillomavirus in healthy individuals: A systematic review of the literature. Sex. Transm. Dis. 2010, 37, 386-391.
36. Gillison, M.L.; Broutian, T.; Pickard, R.K.; Tong, Z.Y.; Xiao, W.; Kahle, L.; Graubard, B.I.; Chaturvedi, A.K. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012, 307, 693-703.
37. Beachler, D.C.; Weber, K.M.; Margolick, J.B.; Strickler, H.D.; Cranston, R.D.; Burk, R.D.; Wiley, D.J.; Minkoff, H.; Reddy, S.; Stammer, E.E.; et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol. Biomark. Prev. 2012, 21, 122-133.
38. Parisi, S.G.; Cruciani, M.; Scaggiante, R.; Boldrin, C.; Andreis, S.; dal Bello, F.; Pagni, S.; Barelli, A.; Sattin, A.; Mengoli, C.; et al. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: A longitudinal cohort study among men who have sex with men. BMC Infect. Dis. 2011, doi:10.1186/1471-2334-11-150.
39. Richter, K.L.; van Rensburg, E.J.; van Heerden, W.F.; Boy, S.C. Human papilloma virus types in the oral and cervical mucosa of HIV-positive South African women prior to antiretroviral therapy. J. Oral Pathol. Med. 2008, 37, 555-559.
40. Beachler, D.C.; D'Souza, G.; Sugar, E.A.; Xiao, W.; Gillison, M.L. Natural history of anal vs. oral HPV infection in HIV-infected men and women. J. Infect Dis. 2013, 208, 330-339.
41. Kreimer, A.R.; Pierce Campbell, C.M.; Lin, H.Y.; Fulp, W.; Papenfuss, M.R.; Abrahamsen, M.; Hildesheim, A.; Villa, L.L.; Salmerón, J.J.; Lazcano-Ponce, E.; et al. Incidence and clearance of oral human papillomavirus infection in men: The HIM cohort study. Lancet 2013, 38, 877-887.
42. Kreimer, A.R.; Villa, A.; Nyitray, A.G.; Abrahamsen, M.; Papenfuss, M.; Smith, D.; Hildesheim, A.; Villa, L.L.; Lazcano-Ponce, E.; Giuliano, A.R. The epidemiology of oral HPV infection among a multinational sample of healthy men. Cancer Epidemiol. Biomark. Prev. 2011, 20, 172-182.
43. Pickard, R.K.; Xiao, W.; Broutian, T.R.; He, X.; Gillison, M.L. The prevalence and incidence of oral human papillomavirus infection among young men and women, aged 18-30 years. Sex. Transm. Dis. 2012, 39, 559-566.
44. Edelstein, Z.R.; Schwartz, S.M.; Hawes, S.; Hughes, J.P.; Feng, Q.; Stern, M.E.; O'Reilly, S.; Lee, S.K.; Fu Xi, L.; Koutsky, L.A. Rates and determinants of oral human papillomavirus infection in young men. Rates and determinants of oral human papillomavirus infection in young men. Sex. Transm. Dis. 2012, 39, 860-867.
45. Du, J.; Nordfors, C.; Ahrlund-Richter, A.; Sobkowiak, M.; Romanitan, M.; Näsman, A.; Andersson, S.; Ramqvist, T.; Dalianis, T. Prevalence of oral human papillomavirus infection among youth, Sweden. Emerg. Infect. Dis. 2012, 18, 1468-1471.
46. Louvanto, K.; Rautava, J.; Willberg, J.; Wideman, L.; Syrjänen, K.; Grénman, S.; Syrjänen, S. Genotype-specific incidence and clearance of human papillomavirus in oral mucosa of women: A six-year follow-up study. PLoS One 2013, 8, e53413.
47. Machado, A.P.; Gatto de Almeida, F.; Bonin, C.M.; Martins Prata, T.T.; Sobrinho Ávilla, L.; Junqueira Padovani, C.T.; Teixeira Ferreira, A.M.; Dos Santos Fernandes, C.E.; Tozetti, I.A. Presence of highly oncogenic human papillomavirus in the oral mucosa of asymptomatic men. Braz. J. Infect. Dis. 2014, 18, 266-270.
48. Tristão, W.; Ribeiro, R.M.; Oliveira, C.A.; Betiol, J.C.; Bettini Jde, S. Epidemiological study of HPV in oral mucosa through PCR. Braz. J. Otorhinolaryngol. 2012, 78, 66-70.
49. Gewirtzman, A.; Bartlett, B.; Tyring, S. Epidermodysplasia verruciformis and human papilloma virus. Curr. Opin. Infect. Dis. 2008, 21, 141-146.
50. Bzhalava, D.; Guan, P.; Franceschi, S.; Dillner, J.; Clifford, G. A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types. Virology 2013, 445, 224-231.
51. Bottalico, D.; Chen, Z.; Dunne, A.; Ostoloza, J.; McKinney, S.; Sun, C.; Schlecht, N.F.; Fatahzadeh, M.; Herrero, R.; Schiffman, M.; et al. The oral cavity contains abundant known and novel human papillomaviruses from the Betapapillomavirus and Gammapapillomavirus genera. J. Infect. Dis. 2011, 204, 787-792.
52. Fatahzadeh, M.; Schlecht, N.; Chen, Z.; Bottalico, D.; McKinney, S.; Ostoloza, J.; Dunne, A.; Burk, R.D. Oral human papillomavirus detection in older adults who have human immunodeficiency virus infection. Oral Surg. Oral Med. Oral Pathol. 2013, 115, 505-514.
53. Forslund, O.; Johansson, H.; Madsen, K.G.; Kofoed, K. The nasal mucosa contains a large spectrum of human papillomavirus types from the Betapapillomavirus and Gammapapillomavirus genera. J. Infect. Dis. 2013, 208, 1335-1341.
54. Söderlund-Strand, A.; Carlson, J.; Dillner, J. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. Modified general primer PCR system for sensitive detection of multiple types of oncogenic human papillomavirus. J. Clin. Microbiol. 2009, 47, 541-546.
55. Forslund, O.; Antonsson, A.; Nordin, P.; Stenquist, B.; Hansson, B.G. A broad range of human papillomavirus types detected with a general PCR method suitable for analysis of cutaneous tumours and normal skin. J. Gen. Virol. 1999, 80, 2437-2443.
56. Lang Kuhs, K.A.; Gonzalez, P.; Struijk, L.; Castro, F.; Hildesheim, A.; van Doorn, L.J.; Rodriguez, A.C.; Schiffman, M.; Quint, W.; Lowy, D.R.; et al. Prevalence of and risk factors for oral human papillomavirus among young women in Costa Rica. J. Infect. Dis. 2013, 208, 1643-1652.
57. De Koning, M.; Quint, W.; Struijk, L.; Kleter, B.; Wanningen, P.; van Doorn, L.J.; Weissenborn, S.J.; Feltkamp, M.; ter Schegget, J. Evaluation of a novel highly sensitive, broad-spectrum PCR-reverse hybridization assay for detection and identification of beta-papillomavirus DNA. J. Clin. Microbiol. 2006, 44, 1792-1800.
58. De Koning, M.N.; ter Schegget, J.; Eekhof, J.A.; Kamp, M.; Kleter, B.; Gussekloo, J.; Feltkamp, M.C.; Bouwes Bavinck, J.N.; Purdie, K.J.; Bunker, C.B.; et al. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types. J. Clin. Microbiol. 2010, 48, 1706-1711.
59. Paolini, F.; Rizzo, C.; Sperduti, I.; Pichi, B.; Mafera, B.; Rahimi, S.S.; Vigili, M.G.; Venuti, A. Both mucosal and cutaneous papillomaviruses are in the oral cavity but only alpha genus seems to be associated with cancer. J. Clin. Virol. 2013, 56, 72-76.
60. Fakhry, C.; Rosenthal, B.T.; Clark, D.P.; Gillison, M.L. Associations between oral HPV16 infection and cytopathology: Evaluation of an oropharyngeal-pap-test equivalent in high-risk populations. Cancer Prev. Res. 2011, 4, 1378-1384.
61. Slebos, R.J.; Jehmlich, N.; Brown, B.; Yin, Z.; Chung, C.H.; Yarbrough, W.G.; Liebler, D.C. Proteomic analysis of oropharyngeal carcinomas reveals novel HPV-associated biological pathways. Int. J. Cancer 2013, 132, 568-579.
62. McMurray, H.R.; McCance, D.J. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J. Virol. 2003, 77, 9852-9861.
63. Patel, J.H.; Loboda, A.P.; Showe, M.K.; Showe, L.C.; McMahon, S.B. Analysis of genomic targets reveals complex functions of MYC. Nat. Rev. Cancer. 2004, 4, 562-568.
64. Descamps, G.; Wattiez, R.; Saussez, S. Proteomic study of HPV-positive head and neck cancers: Preliminary results. Biomed. Res. Int. 2014, doi:10.1155/2014/430906.
65. De Nooij-van Dalen, A.G.; van Dongen, G.A.; Smeets, S.J.; Nieuwenhuis, E.J.; Stigter-van Walsum, M.; Snow, G.B.; Brakenhoff, R.H. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int. J. Cancer 2003, 103, 768-774.
66. Martinez, I.; Wang, J.; Hobson, K.F.; Ferris, R.L.; Khan, S.A. Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas. Eur. J. Cancer 2007, 43, 415-432.
67. Forslund, O. Genetic diversity of cutaneous human papillomaviruses. J. Gen. Virol. 2007, 88, 2662-2669.
68. Antonsson, A.; Hansson, B.G. Healthy skin of many animal species harbors papillomaviruses which are closely related to their human counterparts. J. Virol. 2002, 76, 12537-12542.
69. Forslund, O.; Ly, H.; Higgins, G. Improved detection of cutaneous human papillomavirus DNA by single tube nested-hanging droplet PCR. J. Virol. Methods 2003, 110, 129-136.
70. Li, J.; Pan, Y.; Xu, Z.; Wang, Q.; Hang, D.; Shen, N.; Liu, M.; Zhang, C.; Abliz, A.; Deng, Q.; et al. Improved detection of human papillomavirus harbored in healthy skin with FAP6085/64 primers. J. Virol. Methods 2013, 193, 633-638.
71. Sasagawa, T.; Mitsuishi, T. Novel polymerase chain reaction method for detecting cutaneous human papillomavirus DNA. J. Med. Virol. 2012, 84, 138-144.
72. Berkhout, R.J.; Tieben, L.M.; Smits, H.L.; Bavinck, J.N.; Vermeer, B.J.; ter Schegget, J. Nested PCR approach for detection and typing of epidermodysplasia verruciformis-associated human papillomavirus types in cutaneous cancers from renal transplant recipients. J. Clin. Microbiol. 1995, 33, 690-695.
73. Berkhout, R.J.; Bouwes Bavinck, J.N.; ter Schegget, J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J. Clin. Microbiol. 2000, 38, 2087-2096.
74. Surentheran, T.; Harwood, C.A.; Spink, P.J.; Sinclair, A.L.; Leigh, I.M.; Proby, C.M.; McGregor, J.M.; Breuer, J. Detection and typing of human papillomaviruses in mucosal and cutaneous biopsies from immunosuppressed and immunocompetent patients and patients with epidermodysplasia verruciformis: A unified diagnostic approach. J. Clin. Pathol. 1998, 51, 606-610.
75. Shamanin, V.; Delius, H.; de Villiers, E.M. Development of a broad spectrum PCR assay for papillomaviruses and its application in screening lung cancer biopsies. J. Gen. Virol. 1994, 75, 1149-1156.
76. Harwood, C.A.; Spink, P.J.; Surentheran, T.; Leigh, I.M.; de Villiers, E.M.; McGregor, J.M.; Proby, C.M.; Breuer, J. Degenerate and nested PCR: A highly sensitive and specific method for detection of human papillomavirus infection in cutaneous warts. J. Clin. Microbiol. 1999, 37, 3545-3555.
77. Nindl, I.; Köhler, A.; Gottschling, M.; Forschner, T.; Lehmann, M.; Meijer, C.J.; Snijders, PJ.; Stockfleth, E. Extension of the typing in a general-primer-PCR reverse-line-blotting system to detect all 25 cutaneous beta human papillomaviruses. J. Virol. Method. 2007, 146, 1-4.
78. Michael, K.M.; Forslund, O.; Bacevskij, O.; Waterboer, T.; Bravo, I.G.; Pawlita, M.; Schmitt, M. Bead-based multiplex genotyping of 58 cutaneous human papillomavirus types. J. Clin. Microbiol. 2011, 49, 3560-3567.
79. Antonsson, A.; Michael, K.M.; Pawlita, M.; Lehmann, M.D.; Nindl, I. Detection and typing of cutaneous human papillomavirus types-A comparison of three different methods. J. Virol. Methods 2013, 189, 305-310.
80. Ikenberg, H. Laboratory diagnosis of human papillomavirus infection. Curr. Probl. Dermatol. 2014, 45, 166-174.
81. Mirghani, H.; Amen, F.; Moreau, F.; Guigay, J.; Ferchiou, M.; Melkane, A.E.; Hartl, D.M.; Lacau St Guily, J. Human papilloma virus testing in oropharyngeal squamous cell carcinoma: What the clinician should know. Oral Oncol. 2014, 50, 1-9.